Pharmacist Compensation for Cognitive Services: Focus on the Physician Office and Community Pharmacy

Pharmacotherapy

Volumn 24, Issue 3, 2004, Pages 372-388

  Snella, Kathleen A ^a   Trewyn, Renee R ^b   Hansen, Laura B ^c   Bradberry, J Chris ^d  

^a TEXAS TECH UNIVERSITY HEALTH SCIENCES CENTER   (United States)

^b UNIVERSITY OF OKLAHOMA COLLEGE OF PHARMACY   (United States)

^c UNIVERSITY OF COLORADO   (United States)

^d CREIGHTON UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Billing process; Clinical pharmacist; Cognitive services; Compensation; Payer mix

Indexed keywords

COMPENSATION; FEE; HEALTH CARE DELIVERY; HEALTH INSURANCE; HEALTH SERVICE; HOSPITAL BILLING; HUMAN; LABORATORY; MEDICAID; MEDICARE; PHARMACIST; PHARMACY; REVIEW;

ACCOUNTS PAYABLE AND RECEIVABLE; COMMUNITY PHARMACY SERVICES; DELIVERY OF HEALTH CARE; ECONOMICS, PHARMACEUTICAL; HEALTH EDUCATION; HUMANS; PATIENT EDUCATION; PHARMACISTS; PHYSICIANS' OFFICES; PRACTICE GUIDELINES; TERMINOLOGY; UNITED STATES;

EID: 1542316365     PISSN: 02770008     EISSN: None     Source Type: Journal    
DOI: 10.1592/phco.24.4.372.33179     Document Type: Review

References (51)

1. Gardner JS. Practical guide to establishing vaccine administration services in community pharmacies. J Am Pharm Assoc 1997;NS37:683-93.
2. Bluml BM, McKenney JM, Cziraky MJ. Pharmaceutical care services and results in project ImPACT: hyperlipidemia. J Am Pharm Assoc 2000;40:157-65.
3. Simpson SH, Johnson JA, Tsuyuki RT. Economic impact of community pharmacist intervention in cholesterol risk management: an evaluation of the study of cardiovascular risk intervention by pharmacists. Pharmacotherapy 2001;21:627-35.
4. Rodriguez de Bittner M, Haines ST. Pharmacy-based diabetes management. J Am Pharm Assoc 1997;NS37:443-57.
5. McCallian DJ, Carlstedt BC, Rupp MT. Caring for the asthma patients in a community pharmacy. Am Pharm 1994;NS34:64-75.
6. Woolley BH, Hunt KJ. Managing obesity: a comprehensive approach. US Pharm 1998;23:123-34.
7. Hogue MD. The pharmacist's guide to compensation for patient-care services. Washington, DC: American Pharmaceutical Association, 2002:ix, 1-6, 15-21, 53-9, 61-4, 221.
8. Medicare Payment Advisory Commission. Chapter 3: Medicare coverage of clinical pharmacists services. In: Report to the Congress-Medicare coverage of nonphysician practitioners. June 2002. Available from www.medpac.gov. Accessed December 4, 2002.
9. The American College of Physicians-American Society of Internal Medicine. Pharmacist scope of practice. Ann Intern Med 2002;136:79-85.
10. Nichols J. Pharmacist scope of practice [letter]. Ann Intern Med 2002;136:2W
11. Woods M, Milburn LA. Thoughts on the ACP-ASIM position paper on pharmacist scope of practice. Am J Health-Syst Pharm 2003;60:608-10.
12. Zed PJ, Loewen PS, Jewesson PJ. A response to the ACP-ASIM position paper on pharmacist scope of practice. Am J Health-Sys Pharm 2002;59:1453-6.
13. Nahata MC. Pharmacist's role in health care [editorial]. Ann Pharmacother 2002;36:527-9.
14. Hinthorn DR, Generali JA, Godwin HN. Pharmacist scope of practice: response to position paper. Ann Pharmacother 2002;36:718-20.
15. Cipole RJ, Strand LM, Morley PC. Pharmaceutical care practice. New York: McGraw-Hill, 1998.
16. Centers for Medicare and Medicaid Services. CLIA: general program description. Available from http://www.cms.hhs.gov/clia/progdesc.asp. Accessed February 18, 2003.
17. Centers for Medicare and Medicaid Services. CMS CLIA waived/PPMP laboratory project. Available from http://www.cms.hhs.gov/clia/cowppmp.asp. Accessed February 18, 2003.
18. American Medical Association. CPT 98: physicians' current procedural terminology: professional. Chicago: American Medical Association, 1998.
19. Anonymous. ICD-9-CM: international classification of diseases, 9th revision, clinical modification, 6th ed, color coded, 2003. Salt Lake City: St. Anthony Publishing Inc, 2002.
20. Social Security Administration. Social Security Act. Title XVIII health insurance for the aged and disabled. Available from http://www.ssa.gov/OP_Home/ssact/title18/1800.htm. Accessed February 18, 2003.
21. United States Senate, 107th Congress. Medicare Pharmacist Services Coverage Act of 2001 (S.974). Available from http://thomas.loc.gov. Accessed February 18, 2003.
22. United States House of Representatives, 107th Congress. Medicare Pharmacist Services Coverage Act of 2001 (H.R. 2799). Available from http://thomas.loc.gov. Accessed February 18, 2003.
23. National Community Pharmacists Association, American Pharmaceutical Association, American Society of Consultant Pharmacists. NCPA, APHA, ASCP join forces in support of X12 billing standard for pharmacist professional services [press release April 30, 2002]. Available from www.aphanet.org/news/APhA%20X12.pdf. Accessed September 14, 2003.
24. National Community Pharmacists Association. X12 pharmacy advisory panel holds first meeting [press release October 9, 2002]. Available from www.ncpanet.org/news_press/2002_press/100902.shtml. Accessed September 14, 2003.
25. United States 108th Congress. Medicare Prescription Drug and Modernization Act of 2003 (public law no. 108-173). Available from http://thomas.loc.gov. Accessed January 20, 2004.
26. Mirvis DM, Chang CF, Hall CJ, et al. TennCare: health system in Tennessee. JAMA 1995;274:1235-41.
27. BlueCross BlueShield of Tennessee. Your personal health-diabetes management program. Available from http://www.bcbst.com/health/programs/diabetes.shtm. Accessed February 25, 2003.
28. Snella KA. Specific billing scenarios. In: How to bill for clinical pharmacy services. Kansas City, MO: American College of Clinical Pharmacy, 1999:73-96.
29. North Carolina State Board of Pharmacy. § 90-18.4 (effective July 1, 2000). Limitations on clinical pharmacist practitioners. Available from http://www.ncbop.org/ncbop20-c.htm. Accessed September 14, 2003.
30. Bennett MS, Blank D, Bopp J, James JA, Osterhaus MC. Strategies to improve compensation for pharmaceutical care services. J Am Pharm Assoc 2000;40:747-55, 870-2.
31. Bradberry J, Reed P, George C, et al. Demonstration project on compensation for services and collaborative practice. Presented at the annual meeting of the American Pharmaceutical Association, New Orleans, March 29-April 1, 2003.
32. Fronstin P. Employment-based health care benefits and self-funded employment-based plans: an overview. Washington, DC: Employment Benefits Research Institute, April 2000.
33. Wickman JM, Marquess JG, Jackson RA. Documenting pharmacy care does make cents (and dollars too). Georgia Pharm J 1996;20:12-14.
34. Rosenthal WM, Briggs GC, Rosenthal TG. Ambulatory care clinical skills program: practice management module. Bethesda: American Society of Health-System Pharmacists, 1999:169-86, 225.
35. Trewyn RM. Reimbursement nuances in a community pharmacy. In: How to bill for clinical pharmacy services, 3rd ed. Kansas City, MO: American College of Clinical Pharmacy, 2001:91-126.
36. Tice B, Phillips CR. Implementation and evaluation of a lipid screening program in a large chain pharmacy. J Am Pharm Assoc 2002;42:413-19.
37. Department of Health and Human Services, Centers for Medicare and Medicaid Services. Medicare program: physician fee schedule update for calendar year 2003. Fed Register 2003;68(40):9567-80. Available from http://cms.hhs.gov/provider update/regs/cms1204f2.pdf. Accessed September 1, 2003.
38. Anonymous. Coding and reimbursement guide for pharmacists. Reston, VA: St. Anthony Publishing, Inc., 1999.
39. Graves M, McDonough R. Making reimbursement a reality in pharmaceutical care. Iowa Pharmacist 1997;51:15-21.
40. Poirier S, Buffington DE, Memoli GA. Billing third party payers for pharmaceutical care services. J Am Pharm Assoc 1999;39:50-64.
41. Department of Health and Human Services. Medicare carriers manual. Part 3. Claims process. Transmittal 1764. August 28, 2002. Available from www.cms.hhs.gov/manuals/pm_trans/R1764B3.pdf. Accessed November 12, 2002.
42. Snella KA, Sachdev GP. A primer for developing pharmacist-managed clinics in the outpatient setting. Pharmacotherapy 2003;23:1153-66.
43. Centers for Medicare and Medicaid Services. Documentation guidelines for evaluation and management services. Available from http://cms.hhs.gov/medlearn/masterl.pdf. Accessed February 18, 2003.
44. Piascik P. Simple steps to reimbursement success. Am Pharm 1995;NS35:9-10.
45. Centers for Medicare and Medicaid Services. CLIA general program description. Available from http://cms.hhs.gov/clia/progdesc.asp. Accessed February 18, 2003.
46. Department of Health and Human Services, Centers for Medicare and Medicaid Services. Clinical laboratory improvement amendments of 1988 (CLIA) application for certification. Available from http://www.cms.hhs.gov/forms/cmsl16.pdf. Accessed February 18, 2003.
47. Centers for Medicare and Medicaid Services. State survey agencies (CLIA contact list). Available from http://www.cms.hhs.gov/clia/saaddres.asp. Accessed February 18, 2003.
48. Centers for Medicare and Medicaid Services. How does a provider/supplier enroll in Medicare? Available from http://www.cms.hhs.gov/providers/enrollment/providers/enroll.asp. Accessed February 18, 2003.
49. Weitzel KW, Goode JV. Implementation of a pharmacy-based immunization program in a supermarket chain. J Am Pharm Assoc 2000;40:252-6.
50. Centers for Medicare and Medicaid Services. Mass immunization roster biller. Available from http://www.cms.hhs.gov/providers/enrollment/providers/mirb.asp. Accessed February 18, 2003.
51. McDonough RP, Rovers JP, Currie JD, Hagel H, Vallandingham J, Sobotka J. Obstacles to the implementation of pharmaceutical care in the community setting. J Am Pharm Assoc 1998;38:87-95.